Memory Pharmaceuticals Refocuses to Advance Development and Clinical Programs

Date : 03/12/2008 @ 6:05AM
Source : PR Newswire
Stock : Memory Pharmaceuticals (MM) (MEMY)
Quote : 0.1299  -0.0001 (-0.08%) @ 3:05PM
<< BackQuote Chart Financials

 



Memory Pharmaceuticals Refocuses to Advance Development and Clinical Programs

-Expands PDE10 Collaboration with Amgen-

<< Back


Memory Pharmaceuticals (MM) Historical Chart Memory Pharmaceuticals (MM) Intraday Chart  
Period


LSE and PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2008 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
41 site:2us 081013 15:29 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2005 | 2007 )